This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff, specifically for the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems.
Medical device company Zeto received clearance for its EEG brain monitoring system. The system includes a user-friendly, comfortable EEG headset designed to be easily operated by any medical professional with minimal training.
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
CoraVie Medical, a startup developing an implantable continuous blood pressure monitor, recently won the medical devices track of MedCity News’ INVEST Pitch Perfect contest. The pre-revenue company’s remote management solution monitors for the early detection of dangerous blood pressure levels to prevent crises that could lead to heart attack, stroke, kidney failure or death.
The large-scale, multidisciplinary effort to improve the performance of pulse oximeters provides an example of the value of collaboration to solve problems and shows how industry partners can contribute in a significant way when they have a seat at the table.
A group of 24 novel startups were selected to pitch at MedCity News' INVEST conference in Chicago. Here's four that VC judges chose as the winners in their respective tracks.
Click Therapeutics is acquiring the assets of Better Therapeutics two months after that digital therapeutics developer announced it would lay off all employees and shut down. Better’s main asset is AspyreRx, an FDA-authorized mobile app for type 2 diabetes.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Fem Therapeutics won the audience choice award in the Canadian PItch contest at MedCity INVEST in Chicago this week. It competed with Reach Orthopaedics , PragmaClin Research, and OPTT Health.
The boutique healthcare investment conference in Chicago is scheduled for May 21-22. Space is limited so register today!
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
The group of four healthcare startups spans women's health, orthopedics, remote patient monitoring for Parkinson's disease, AI, and 3D printing. David Kereiakes, Managing Partner, Windham Venture Partners will moderate the session.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Abbott earned FDA approval for its dissolving stent designed to unclog arteries below the knee. This marks the first time the FDA has approved a stent or drug-coated balloon to help arteries stay open below the knee.
The diagnostics/medical device track focuses on cardiology this year.
Routine NM-MRI for individuals at risk of Parkinson's could provide a means of identifying the disease before symptoms emerge.
A much diminished 23andMe exists today, a far cry from the phenomenon that it was in the world consumer DNA testing. Could things have unfolded differently under a different leader with a different vision?
The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories. The devices are not currently being removed from the market.